Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kangbuk Samsung Hospital
Primary objective - Incidence of newly developed diabetes mellitus in patients with colorectal cancer after post-operative chemotherapy
Secondary objective - Pre-operative incidence of diabetes and characteristics of metabolic parameters of patients with colorectal cancer; Incidence of developed poorly controlled glucose level in diabetic patients with colorectal cancer after post-operative chemotherapy; 3-year recurrence-free survival according to status of diabetes and metabolic parameters; 5-year recurrence-free survival according to status of diabetes and metabolic parameters
Age
20–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Who will get surgical resection for colorectal cancer
Who has diagnosed with diabetes
Who met the criteria for testing of diabetes in asymptomatic adult individuals
Criteria for testing for diabetes in asymptomatic adult individuals
* overweight (BMI\>25 kg/m2\*) and have additional risk factors (physical inactivity, first-degree relative with diabetes, high-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander), women who delivered a baby weighing 0.9 lb or were diagnosed with GDM, hypertension (\>140/90 mmHg or on therapy for hypertension), HDL cholesterol level ,35 mg/dL (0.90 mmol/L) and/or a triglyceride level \>250 mg/dL (2.82 mmol/L), women with polycystic ovarian syndrome, HbA1C \>5.7%, IGT, or IFG on previous testing, other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans), history of CVD)
You may not be if
Previously exposed to surgery or chemotherapy for colorectal cancer
Second primary malignancy (except in situ carcinoma of the cervix or adequately treated basal cell carcinoma of the skin or prior malignancy treated more than 5 years ago without recurrence
Presence of CNS metastasis
Not able or willing to give informed consent
Any patients judged by the investigator to be unfit to participate in the study
Clareo Health | Surveillance of Metabolic Parameters in Patients With Colorectal Cancer
